Brett P. Monia, Chief Executive Officer at IONIS PHARMACEUTICALS INC (IONS), sold 24,000 shares at $49.64 ($1.2M) on 2023-12-20, disclosed to the SEC on 2023-12-22.
Scheduled sale ($1.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.64 | 6,500 | $323K | 27.2% |
| 2 | $49.29 | 17,500 | $863K | 72.8% |
| Total | $49.38 avg | 24,000 | $1.2M | 100% |
| Filing → |
| IONS | SELL | 2026-03-11 | $24.2M | — | Filing → |
| IONS | SELL | 2026-02-10 | $2.5M | — | Filing → |
| IONS | SELL | 2026-02-02 | $5.2M | — | Filing → |